Werewolf Therapeutics, Inc.
HOWL
$0.39
$0.001.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 120.41% | 25.19% | 58.92% | 1.82% | -4.25% |
| Total Depreciation and Amortization | 503.94% | -6.57% | -9.50% | -11.45% | -10.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.51% | -57.50% | -94.58% | -22.59% | 22.57% |
| Change in Net Operating Assets | -3,253.33% | 138.68% | -204.53% | -193.17% | -112.73% |
| Cash from Operations | 143.72% | 44.07% | 22.65% | -21.62% | -6.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.74% | -- | -7.11% | -- | -59.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8,453.61% | -- | -7.11% | 54,666.67% | 103.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.68% | 44.07% | 26.80% | 4.72% | 38.21% |